ConcertAI Announces Strategic Agreement with Bayer to Accelerate Clinical Development in Precision Oncology
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ConcertAI announced a multi-year agreement with Bayer to leverage ConcertAI's Translational360™ and AI SaaS solutions, which use artificial intelligence and machine learning (AI/ML)-derived insights to accelerate clinical development in precision oncology.
The agreement will fully leverage ConcertAI's newly launched Translational360™, an integrated research-grade longitudinal clinical molecular database that taps into the CancerLinQ network of de-identified cancer patient data from over 9 million records coming from all 50 states in the U.S.
Translational360™ combines clinical, genomic, transcriptomic, and whole-slide imaging (WSI) from comprehensive molecular testing for deep phenotypical and genomic insights. Transcriptomics is increasingly a foundation of biopharma translational sciences, allowing researchers to understand disease molecular mechanisms, basis of patient response, and inter-patient variability that's essential for developing new therapeutics. Too often, clinical trial results in early phases are ambiguous with idiosyncratic positive and negative responses. The integrated data solutions and advanced AI enable selection of programs with the highest likelihood of success and design trials informed by multi-modal, multi-genomic, and transcriptomic data and AI.
'This partnership furthers causal biological inferences where multi-modal and multi-molecular data can be integrated with AI/ML-based approaches across discovery, translation, and development, accelerating oncology pipelines, allowing our biopharma partners to deliver better medicines faster,' said Jeff Elton, Ph.D., CEO of ConcertAI. 'This partnership builds on a multi-year history of working together and is unique in offering both tissue and liquid biopsy molecular data, allowing insights into patterns of treatment response, acquisition of resistance, AI modeling of likely success and benefit, informing program priority and clinical study design.'
'As cancer rates continue to rise, we're committed to advancing next-generation solutions that can speed up drug discovery and clinical development, enabling us to bring precision oncology treatments to patients faster,' said Sai Jasti, Head of Data Science and AI for Pharma R&D at Bayer. 'By combining ConcertAI's powerful data solutions with Bayer's scientific and AI expertise, we aim to enhance the use of real-world data and cutting-edge AI to boost R&D productivity and ultimately deliver transformative precision therapies to those who need them.'
'More AI-designed new molecular entities are progressing faster in first-in-human trials which is a great milestone,' said Claudio D'Ambrosio, Ph.D., Chief Revenue Officer of ConcertAI. 'Our entire R&D process has been historically built on studying controlled cell lines and animal models that don't reflect the interspecies differences, the physiology, and the different biological barriers we have in humans. We are flipping this paradigm on its head. We need to start with human cancer genomes and phenotypes and 'reverse translate.' Unlike only a few years ago, we now have powerful human data.'
About ConcertAI:
ConcertAI is a leader in predictive and generative AI SaaS and multi-modal real-world data research solutions for healthcare and life sciences. Our mission is to accelerate insights and outcomes for patients through research-ready data, CARAai ™ technologies, and scientific expertise in partnership with over 46 leading biomedical innovators, 2,000 healthcare providers, and medical societies. TeraRecon® provides advanced radiological image visualizations and clinical AI decision augmentation solutions for MRI and CT. CancerLinQ® is an initiative of ConcertAI, empowering oncology providers with ASCO-aligned automated QOPI and ASCO Certified® quality solutions and SmartLinQ™ analytic services. Headquartered in Cambridge, MA, ConcertAI has offices in Bangalore, Frankfurt, Philadelphia, Raleigh-Durham, and Tokyo. For more information, visit us at concertai.com.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
16 minutes ago
- Business Wire
AI Time Platform Laurel Raises $100 Million to Transform the Professional Services Industry
SAN FRANCISCO--(BUSINESS WIRE)--Laurel, the world's first AI Time platform, today announced it has raised $100 million in Series C funding led by IVP, with participation from GV (Google Ventures). Laurel will leverage this investment to scale its AI time platform and accelerate to solve what it calls the 'time intelligence challenge"—the inability for knowledge industries to accurately map time to business outcomes. In the age of AI, quantifying and understanding human capital goes from a 'nice to have' to a 'cannot exist without' for enterprises. In addition to IVP and GV, new investors in the round, which consists of primary and secondary funding, also include: 01.a (created by former CEO and COO of Twitter & CRO of Facebook), DST Global, Kevin Weil (CPO @ OpenAI), Alexis Ohanian, Vladimir Fedorov (CTO @ GitHub), Arash Ferdowsi (co-founder of Dropbox), and Hans Tung. These investors join returning investors ACME, Anthos, Gokul Rajaram, AIX Ventures, and Marc Benioff's TIME Ventures. The funding comes as Laurel experiences rapid adoption among enterprise professional services firms like Ernst & Young, Grant Thornton, Freshfields, and Crowell & Moring. Over the last 12 months, Laurel grew ARR +300% at double-digit scale, increased usage by +500%, and works with +100 of the top legal, accounting, and consulting firms across US, UK, EU, Australia, and Canada. Laurel's AI Time platform, now leveraged by hundreds of the world's top enterprise professional service firms, uses AI to automatically categorize, describe, and analyze how professionals spend their time on admin work. The platform's ability to connect time data with business outcomes has proven transformative for firms looking to maximize profits, allocate their resources effectively, and understand exactly what workflows to apply AI to and what agents to automate. Customers using the company's AI-native time platform report profit increases between 4-11%—driven by an additional 28 billable minutes per day per professional, and increased realization of 1-4%. Laurel's ROI methodology has been independently audited and validated by a Big-4 Firm. The platform currently processes over $5B in gross market value for its customers, and +$360M of that amount is net-new value attributable to Laurel. In addition, Laurel saves its professionals up to 80% in time recording, freeing them to work on high-leverage work. 'Laurel uniquely delivers value across lawyers, clients, finance, and marketing by streamlining time capture, enriching narratives, and accelerating accurate billing,' says Reed Cunningham, Chief Innovation Officer at global law firm Reed Smith. 'As firms assess the impact of AI and fixed fees, gaining granular intelligence with less effort is essential to redefining value within a firm and for its clients.' 'I've seen first-hand how Laurel can transform our approach to time intelligence. What used to be a manual process of time-keeping and entry is now significantly technology enabled,' says Matt Newnes, Partner and Tax Transformation leader at Ernst & Young. 'Laurel doesn't just help our people to capture time that they spend on work more comprehensively; it helps us to understand much more about how our teams work allowing us to identify best practices to help ensure we always drive the best outcomes for our clients. It has proven to be one of our most impactful AI investments, delivering measurable results while laying the foundation for broader transformation initiatives.' Automating time is Laurel's first step. Laurel's AI platform turns its proprietary data around work and time to address the #1 business problem impacting knowledge industries: operating without visibility into their supply chain. 'Nobody has ever mapped the input of time to the output of outcomes. Industries like legal and accounting are best at understanding their input (time), but still struggle to price value. On the flip side, industries like consulting and financial services understand value, but operate blind to the true cost of creation. While all other industries have been obsessed about optimizing their supply chain, the supply chain of knowledge work—which represents over 50% of Global GDP—has never been surfaced. This funding helps us solve this fundamental challenge while giving firms the data foundation they need to deploy AI strategically. We're not just automating time—we're creating the time intelligence layer that will transform how all knowledge industries operate," says Ryan Alshak, founder and CEO of Laurel. "Laurel has identified one of the largest efficiency gaps in the modern economy, one I understand deeply as a former CFO of a public company. Professional services represent trillions in global economic activity, yet these firms operate without basic visibility into their core resource – time. By solving the time intelligence challenge, Laurel creates a platform for broader AI transformation. As these industries invest heavily in AI over the next five years, Laurel's data foundation becomes essential infrastructure that truly tracks the ROI of AI. The market opportunity is massive, and Laurel's unique position makes them the clear leader in this space," says Ajay Vashee, General Partner at IVP. 'Laurel is creating the enterprise intelligence layer for knowledge work that leverages timekeeping as a product wedge,' said Frederique Dame, General Partner at GV. 'By capturing and organizing the full lifecycle of how professionals spend their time, Laurel unlocks a new class of data that makes work itself measurable, optimizable, and automatable. The goal isn't just better time tracking, it's building the data foundation for AI-powered workflows, predictive resourcing, and strategic insights.' Transforming How Knowledge Industries Understand and Optimize Work While manufacturing companies know exactly how much it costs to produce a car down to the penny, and retail businesses track inventory with precision, professional services firms have historically operated without understanding their most critical resource: human capital. Both the outcomes of the work itself and the time it takes to produce it. As a result, organizations are operating blind on what the biggest impact for AI is across their companies, and how to point people to highest value tasks (like Business Development, Relationship Management, and first principles strategic thinking). As knowledge industries plan to spend over $1 trillion on AI in the next five years, Laurel's time intelligence platform ensures these investments target the highest-impact opportunities. Key customer results include: Average recovery of 28+ billable minutes per professional per day 4-11% increase in overall firm profitability 80%+ reduction in time spent on manual time entry Real-time visibility into project profitability and resource utilization 'While Laurel is unique in that it is AI that generates profits, the reason everyone at Laurel cares so much about solving this problem is because people waste so much time at work, and the only way to solve this at scale is to deeply understand where that time is going,' says Alshak. 'And we're starting with professional services because that will give us the human-in-the-loop required to create the world's first-ever agentic timesheet. The average knowledge worker works 9 hours a day, but only adds leverage for 3. That is 3 hours a day we're doing work that should be done by agents, and 3 hours a day we're doing work that nobody should do. That is our opportunity set – 6.4 billion years currently being spent by knowledge workers on tasks humans no longer need to do. That is our opportunity.' About Laurel Laurel is the world's first AI Time platform for professional services firms. The company's AI transforms how organizations track, analyze, describe, and optimize their most valuable resource: time. By automating work time and connecting time data to business outcomes, Laurel enables firms to increase profitability, improve client delivery, and make data-driven strategic decisions. Founded in 2018, Laurel serves many of the world's largest accounting, consulting and law firms. For more information, visit About IVP IVP supercharges growth in breakout companies, converting momentum into market dominance. One of the original venture firms on Sand Hill Road, IVP partners with companies that define their eras—from Slack, Crowdstrike and Coinbase to Perplexity, Abridge, Glean and Chainguard—before the world truly appreciated them. Each year, IVP invests in just a dozen breakout founders ready to scale from millions to hundreds of millions in revenue and expand from one market to many. We've guided market leaders through cycles and storms, unlocking pivotal growth by activating the right expertise at the moments founders need it. With 130+ IPOs out of 400 investments, IVP helps ambitious founders defy limits, command industries and cement their place at the top.
Yahoo
32 minutes ago
- Yahoo
DEEPX and Wind River Collaborate to Advance Mission-Critical Edge AI Applications
SEOUL, South Korea & ALAMEDA, Calif., June 10, 2025--(BUSINESS WIRE)--DEEPX, a pioneering on-device AI semiconductor company, and Wind River, a global leader in delivering software for the intelligent edge, have collaborated on a hardware and software solution for next-generation edge AI. The partnership combines DEEPX's on-device AI semiconductors with Wind River's VxWorks® real-time operating system (RTOS) and Wind River® Helix™ Virtualization Platform to help advance solutions for mission-critical industries such as aerospace, defense, industrial, and robotics. "Edge AI is on a path to unlock incredible opportunities across a diverse range of industries. Together with Wind River's long heritage in software for markets that are highly dependent on safety, security, reliability, and edge expertise, DEEPX can provide customers with innovative edge AI platforms that deliver exceptional performance, cost, and power efficiency," said Lokwon Kim, CEO, DEEPX. "The growth of real-time physical AI is creating immense potential for mission-critical environments while also presenting new, complex challenges. The collaboration between DEEPX's advanced AI semiconductors and Wind River's proven edge technologies will help advance AI to deliver tremendous outcomes across applications and industries," said Avijit Sinha, Senior Vice President, Strategy and Global Business Development, Wind River. With the enablement of DEEPX's neural processing units (NPUs) on Wind River technologies, companies can easily add accelerated AI to their real-time or edge systems, at lower cost. DEEPX and Wind River work to deliver a pre-validated solution stack that addresses safety and security issues, helping companies significantly reduce complexity and development cycles. A leader in on-device AI, DEEPX develops advanced AI semiconductors that optimize performance, reduce power consumption, and enhance cost efficiency across various industries, including smart camera modules, smart mobility, smart factories, consumer electronics, smart cities, surveillance systems, and AI servers. DEEPX's cutting-edge AI chips are engineered for maximum efficiency and effortless integration into any device. Market-leading VxWorks is the industry's most trusted and widely deployed RTOS for mission-critical systems that must be secure and safe. The first commercial RTOS to support Open Container Initiative (OCI)–compliant containers, VxWorks enables companies to rapidly deploy new software-defined capabilities. Helix Platform is a hypervisor solution that enables engineering teams to consolidate multiple systems onto a single high-performance embedded system. It streamlines safety certification, reduces project risk, and accelerates time-to-market. About DEEPX DEEPX is leading the next-generation semiconductor market with its innovative AI technology and global competitiveness. The company has filed over 300 patents worldwide and registered more than 70, securing world-class proprietary AI semiconductor technology assets. DEEPX has been listed in the EE Times "Silicon 100" for two consecutive years and was named "Best Company in the AI Semiconductor Industry" by U.S. market research firm Frost & Sullivan. DEEPX continues solidifying its position as a key player in the AI semiconductor market through its global achievements and recognition for its innovation and technological leadership. About Wind River Wind River is a global leader in delivering software for the intelligent edge. For more than four decades, the company has been an innovator and pioneer, powering billions of devices and systems that require the highest levels of security, safety, and reliability. Wind River software and expertise are accelerating digital transformation across industries including automotive, aerospace, defense, industrial, medical, and telecommunications. The company offers a comprehensive portfolio supported by world-class global professional services and support and a broad partner ecosystem. To learn more, visit Wind River at Wind River is a trademark or registered trademark of Wind River Systems, Inc., and its affiliates. Other names may be the trademarks of their respective owners. View source version on Contacts MEDIA CONTACT Jenny SuhWind
Yahoo
32 minutes ago
- Yahoo
Backing the Future of Global Biotech: Reynold Lemkins' Strategy Across Borders and Stages
HONG KONG, June 10, 2025--(BUSINESS WIRE)--Reynold Lemkins Group, an international investment firm focused on value-driven cross-border capital deployment, announced the continued advancement of its strategic focus in late-stage healthcare, AI-powered therapeutics, and Asia-centered biotech commercialization. As part of this strategy, Reynold Lemkins recently participated in the IPO of VISEN Pharmaceuticals on the Hong Kong Stock Exchange (HKEX: 02561). VISEN, a biopharmaceutical company specializing in long-acting growth hormone therapies, attracted strong institutional demand and represents the kind of regulatory-validated, commercially scalable business the firm targets. Reynold Lemkins invested alongside globally recognized healthcare investors including HongShan Capital Group (previously Sequoia China), Sofinnova, Vivo Capital, OrbiMed, and WuXi Biologics (HKEX: 2269), reinforcing its commitment to cross-border innovation and long-term capital alignment. This investment underscores Reynold Lemkins' broader strategy of supporting science-driven, late-stage companies with scalable market potential—particularly those operating at the convergence of AI, therapeutics, and Asia-Pacific commercialization. "Our approach focuses on more than capital—we provide strategic insight and cross-border connectivity to help companies scale," said Kris Haoran Liu, President and Chief Investment Officer at Reynold Lemkins Group. "Biotech firms entering public markets need partners who understand both the science and the structure of global growth." With Asia playing an increasingly pivotal role in global healthcare, Reynold Lemkins sees a growing need for capital strategies that link scientific innovation with scalable regional execution. At the same time, the firm closely tracks trends in the U.S. and other mature markets, where biotech companies are navigating longer paths to liquidity and require strategic partners with global reach. Reynold Lemkins positions itself at this intersection—bridging East and West, public and private markets—to support companies shaping the next era of patient-centered care. To learn more, visit follow us on LinkedIn, or explore our insights on Medium. View source version on Contacts Reynold Lemkins Groupreynoldlemkins@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
